Protocol for Outcome Evaluation of Ayahuasca-Assisted Addiction Treatment: The Case of Takiwasi Center
Brian Rush, Olivia Marcus, Sara Mallén García, Anja Loizaga-Velder, Gabriel Loewinger, Ariane Spitalier, Fernando Mendive
Frontiers in Pharmacology May 19, 2021 DOI: 10.3389/fphar.2021.659644 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Protocol description Qualitative Peer reviewed |
|---|---|
| Interventions | Ayahuasca-assisted integrative treatment model |
| Topics | Addiction Ayahuasca |
| Keywords | Context archaeology Protocol science Focus group Addiction treatment Intervention counseling Rehabilitation Data collection Outcome game theory Psychotherapist Alternative medicine Physical therapy |
| Citations | 26 |
| Key points | The ATOP protocol uses a mixed-methods approach to evaluate an ayahuasca-assisted addiction treatment model, focusing on the significance of treatment setting for outcomes. |
Abstract
The present study describes the protocol for the Ayahuasca Treatment Outcome Project (ATOP) with a special focus on the evaluation of addiction treatment services provided through Takiwasi Center, the first ATOP study site. The goal of the project is to assess treatment outcomes and understand the therapeutic mechanisms of an Ayahuasca-assisted, integrative treatment model for addiction rehabilitation in the Peruvian Amazon. The proposed intervention protocol highlights the significance of treatment setting in the design, delivery, and efficacy of an addiction rehabilitation program that involves the potent psychedelic tea known as Ayahuasca. After describing the context of the study, we put forth details about our mixed-methods approach to data collection and analysis, with which we seek to gain an understanding of why, how, and for whom this specific ayahuasca-assisted treatment program is effective across a range of outcomes. The ATOP protocol employs qualitative research methods as a means to determine which aspects of the setting are meaningful to clients and practitioners, and how this may correlate with outcome measures. This paper delineates the core principles, methods, and measures of the overall ATOP umbrella, then discusses the role of ATOP in the context of the literature on long-term residential programs. To conclude, we discuss the strengths and limitations of the protocol and the intended future of the project.
Citations in the library
Cited by 24
- Classic and non‐classic psychedelics for substance use disorder: A review of their historic, past and current research Addiction Neuroscience June 22, 2022
- Psychedelic-induced mystical experiences: An interdisciplinary discussion and critique Frontiers in Psychiatry April 5, 2023
- Ayahuasca: A review of historical, pharmacological, and therapeutic aspects. Psychiatry and Clinical Neurosciences Reports December 1, 2023
- Psychotherapeutic and neurobiological processes associated with ayahuasca: A proposed model and implications for therapeutic use Frontiers in Neuroscience January 31, 2023
- Psychedelic Science, Contemplative Practices, and Indigenous and Other Traditional Knowledge Systems: Towards Integrative Community-Based Approaches in Global Health. Journal of Psychoactive Drugs 2023
and 19 more in the library
Cites 82
- Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial Journal of Psychopharmacology November 30, 2016
- Psilocybin-assisted treatment for alcohol dependence: A proof-of-concept study Journal of Psychopharmacology January 13, 2015
- REBUS and the Anarchic Brain: Toward a Unified Model of the Brain Action of Psychedelics Pharmacological Reviews June 20, 2019
- Psilocybin with psychological support for treatment-resistant depression: six-month follow-up. Psychopharmacology November 8, 2017
- Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction Journal of Psychopharmacology September 11, 2014
and 77 more in the library